We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.71B
AUM Growth
+$94.7M
Cap. Flow
-$7.02M
Cap. Flow %
-0.41%
Top 10 Hldgs %
35.58%
Holding
214
New
17
Increased
63
Reduced
81
Closed
2

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$6.46M
2
GEV icon
GE Vernova
GEV
+$3.39M
3
MRK icon
Merck
MRK
+$2.86M
4
GLW icon
Corning
GLW
+$2.26M
5
MSFT icon
Microsoft
MSFT
+$1.88M

Sector Composition

Rank Sector Weight
1 Technology 29.47%
2 Industrials 19.05%
3 Healthcare 14.75%
4 Financials 9.62%
5 Materials 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
26
Alphabet (Google) Class A
GOOGL
$4.12T
$21.8M 1.28%
123,906
+6,923
+6% +$1.13M
TDY icon
27
Teledyne Technologies
TDY
$29.2B
$20.7M 1.21%
40,384
+220
+0.5% +$106K
AAPL icon
28
Apple
AAPL
$4.97T
$19.8M 1.16%
96,300
+2,022
+2% +$408K
NVS icon
29
Novartis
NVS
$302B
$19.6M 1.15%
162,307
-918
-0.6% -$103K
PG icon
30
Procter & Gamble
PG
$340B
$19.1M 1.12%
119,872
+334
+0.3% +$54.5K
HXL icon
31
Hexcel
HXL
$7.97B
$18.9M 1.11%
334,285
+4,139
+1% +$219K
SNY icon
32
Sanofi
SNY
$107B
$18.6M 1.09%
385,188
-2,742
-0.7% -$140K
REGN icon
33
Regeneron Pharmaceuticals
REGN
$72.9B
$18.5M 1.08%
35,205
+1,998
+6% +$1.12M
AZO icon
34
AutoZone
AZO
$51.3B
$17.9M 1.05%
4,828
-33
-0.7% -$122K
SHEL icon
35
Shell
SHEL
$244B
$17.7M 1.04%
251,887
-2,399
-0.9% -$161K
WY icon
36
Weyerhaeuser
WY
$17.6B
$17.1M 1%
664,310
-1,759
-0.3% -$46K
CVX icon
37
Chevron
CVX
$382B
$16.8M 0.99%
117,510
+1,433
+1% +$202K
JNJ icon
38
Johnson & Johnson
JNJ
$640B
$16.7M 0.98%
109,652
-405
-0.4% -$62.3K
ALB icon
39
Albemarle
ALB
$13.4B
$15.9M 0.93%
254,183
+11,147
+5% +$659K
MTD icon
40
Mettler-Toledo International
MTD
$28.1B
$15.7M 0.92%
13,388
+409
+3% +$457K
PPG icon
41
PPG Industries
PPG
$24.9B
$15.5M 0.91%
136,292
+5,661
+4% +$612K
MRK icon
42
Merck
MRK
$322B
$15.3M 0.89%
192,968
-35,972
-16% -$2.86M
ROK icon
43
Rockwell Automation
ROK
$51.1B
$15.2M 0.89%
45,714
+301
+0.7% +$85.7K
CTSH icon
44
Cognizant
CTSH
$26.5B
$14.5M 0.85%
185,710
+582
+0.3% +$44.6K
XOM icon
45
ExxonMobil
XOM
$650B
$11.4M 0.67%
105,641
-591
-0.6% -$63.2K
BRK.A icon
46
Berkshire Hathaway Class A
BRK.A
$1.1T
$10.9M 0.64%
15
-2
-12% -$1.52M
DVN icon
47
Devon Energy
DVN
$51.3B
$10.2M 0.6%
321,756
+8,709
+3% +$277K
VRTX icon
48
Vertex Pharmaceuticals
VRTX
$123B
$8.14M 0.48%
18,287
+141
+0.8% +$65K
ECL icon
49
Ecolab
ECL
$79.8B
$8.1M 0.47%
30,054
+70
+0.2% +$17.8K
TMO icon
50
Thermo Fisher Scientific
TMO
$214B
$7.98M 0.47%
19,686
+38
+0.2% +$15.9K

Similar funds

Grandfield & Dodd's Q2 2025 Portfolio in Review

As of Q2 2025, Grandfield & Dodd held 214 positions worth $1.71B, up 5.9% from $1.61B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Grandfield & Dodd's Q2 2025 filing shows 17 new, 63 increased, 81 reduced and 2 closed positions. Its largest new stake was iShares S&P 500 Growth ETF: 8,430 shares worth $928K. The largest sale was Gilead Sciences, an estimated $6.46M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Industrials and Healthcare.

  • Grandfield & Dodd's largest Q2 2025 buy was iShares S&P 500 Growth ETF: 8,430 shares worth $928K.
  • Grandfield & Dodd added most to Applied Materials in Q2 2025, an estimated $4.75M increase.
  • Grandfield & Dodd's biggest Q2 2025 reduction was Gilead Sciences, cutting an estimated $6.46M.
  • Grandfield & Dodd fully exited Discover Financial Services in Q2 2025, selling an estimated $406K.
  • Grandfield & Dodd's ten largest holdings make up 36% of its $1.71B portfolio in Q2 2025.
  • Grandfield & Dodd opened 17 new positions and closed 2 in Q2 2025.
  • Grandfield & Dodd's portfolio value rose 5.9% quarter-over-quarter to $1.71B.

Based on Grandfield & Dodd's 13F filing for Q2 2025, filed 8 Aug 2025.